Skip to main content

Quick Connect

Meet our API specialists at

CPhI NA 2022!

Explore innovation, learning, sourcing,
and networking opportunities

Get Started

Our Team at CPhI North America

  • Rajesh Sadanandan

    Vice president Sales & Marketing

  • Jaime Macke

    Manager, Business Development - North America

  • Juli Asmonga

    Associate Vice President, Business development

About CPhI North America

CPhI organises the world's most prominent pharmaceutical events. At, CPhI events, more than 500,000 influential and renowned pharma players connect to learn, grow, and do business. With a 30-year-old legacy and an infrastructure capable of uniting buyers, sellers, and industry pioneers, CPhI extended its iconic global events portfolio into the world's most progressive mega-market, North America.

The US alone accounts for 40% of worldwide pharmaceutical sales and hosts six of the world's top eleven pharmaceutical corporations. Additionally, the US market offers an unparalleled platform for community growth and thought leadership, while functioning as a hub for innovation. Most significantly, CPhI North America brings it all to life.

Know More

About Us

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.

Dr.API Reddy's business operates in a number of global markets, including the United States of America, Europe, India, Russia, and other CIS nations.


Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.

Learn More

Our Achievements


No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.


Have you booked your
CPHI Japan meeting slot yet?

Join us at booth: 5N-12

17th-19th April 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan

Schedule a meeting